Phase 1b/2 Study of AMG 479 in Combination With Paclitaxel and Carboplatin for 1st Line Treatment of Advanced Squamous Non-Small Cell Lung Cancer

This study has been terminated.
(Based upon data from a similar NSCLC study, it was decided to permanently discontinue enrollment in the 20080257 study.)
Sponsor:
Information provided by:
Amgen
ClinicalTrials.gov Identifier:
NCT00807612
First received: December 11, 2008
Last updated: August 4, 2011
Last verified: August 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2010
  Primary Completion Date: August 2010 (Final data collection date for primary outcome measure)